Compare
Dayvigo vs. Belsomra

Dayvigo (lemborexant) CIV is a medication that's used to help adults who have trouble falling or staying asleep (insomnia). This sleep medication belongs to the drug class called orexin receptor antagonists. The typical dosage for the Dayvigo (lemborexant) tablets is 5 mg or 10 mg that's taken by mouth right before bedtime. You should take the medication only if you know you can get at least 7 hours of sleep before you need to wake up the next day. Common side effects include sleepiness and headache. Dayvigo (lemborexant) is a controlled substance because it has a risk for misuse.

• Trouble falling asleep or staying asleep (insomnia)

• Feeling sleepy or tired (up to 10%)
• Headache (up to 6%)
• Nightmares or unusual dreams (up to 2%)

• Daytime sleepiness
• Suicidal thoughts and behaviors or worsening depression
• Sleep paralysis, hallucinations, and cataplexy-like symptoms
• Abnormal sleep behaviors
• Use with caution in people with breathing problems

Belsomra (suvorexant) is used to treat insomnia in adults. It's helpful for those who have a hard time falling asleep or staying asleep. This sleep medication belongs to the drug class called orexin receptor antagonists. You take a dosage within 30 minutes of bedtime as needed for sleep. It's common to feel drowsy the next day as a side effect. Belsomra (suvorexant) is a controlled substance because of the risk of misuse and becoming habit-forming. It's available as a brand-name medication only.

• Insomnia (trouble falling asleep or staying asleep)

• Drowsiness (7%)
• Headache (7%)

• Feeling drowsy and having trouble focusing the next day
• Risk of worsening of depression and suicidal thoughts
• Doing things while asleep
• Sleep paralysis, hallucinations, and weakness in the legs
• Caution use in people with breathing problems